For the Inventor, By the Inventor

Enter assignee name

Ono Pharmaceuticals Co., Ltd.

Calculating rank

USPTO Granted Patents = 22

% Expired Patents = 63.6

Forward Citations = 130

Loading Chart...

Loading Chart...

64 inventors (with patents filed for the assignee):

Shinji Nakade (3 out of 17 patents)

Hiromu Habashita (3 out of 17 patents)

Fumio Nambu (3 out of 10 patents)

4. Shuichi Ohuchida (3 out of 43 patents)

5. Tohru Kambe (2 out of 18 patents)

6. Kousuke Tani (2 out of 33 patents)

7. Toru Maruyama (2 out of 21 patents)

8. Shinsaku Yamane (2 out of 11 patents)

9. Satoshi Nakayama (2 out of 10 patents)

10. Jun Takeuchi (2 out of 23 patents)

11. Shiro Shibayama (2 out of 52 patents)

12. Takayuki Maruyama (2 out of 20 patents)

13. Masaya Kokubo (2 out of 15 patents)

14. Yoshikazu Takaoka (2 out of 23 patents)

15. Kaoru Kobayashi (2 out of 40 patents)

22 patents: Sort by Forward Citations

1. 10501442 - Quinoline derivative (2019-12-10),

2. 9403867 - Methods of producing anamorelin hydrochloride having controlled chloride content (2016-08-02),

3. 9388157 - Bicyclic compound and use thereof for medical purposes (2016-07-12),

4. 8765783 - Pharmaceutical composition for treatment of disease due to vascular constriction or vasodilation (2014-07-01),

5. 8748485 - Compound and medical use thereof (2014-06-10),

6. 8614340 - Bicyclic compound and use thereof for medical purposes (2013-12-24),

7. 8115014 - Ethynylindole compounds (2012-02-14),

8. 7968572 - Nitrogen-containing heterocyclic compound and pharmaceutical application thereof (2011-06-28),

9. 7629369 - N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation (2009-12-08),

10. 7498323 - Spiro-piperidine compounds and medicinal use thereof (2009-03-03),

11. 7300917 - Remedy for chronic disease (2007-11-27),

12. 7291644 - Indole derivatives (2007-11-06),

13. 7288558 - Pharmaceutical composition for treatment for urinary diseases comprising LPA receptor regulator (2007-10-30),

14. 7285552 - Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient (2007-10-23),

15. 7273725 - Human and mammalian stem cell-derived neuron survival factors (2007-09-25),

Company Overview

Ono Pharmaceuticals Co., Ltd. is a prominent biopharmaceutical company based in Osaka, Japan, specializing in the research, development, and manufacturing of innovative therapeutic solutions. The company focuses on various therapeutic areas, including oncology, immunology, and central nervous system disorders, leveraging advanced technologies to address unmet medical needs. Ono is committed to enhancing patient outcomes through its dedication to scientific excellence and collaboration with global partners in the pharmaceutical industry.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

22 Patents

#299 in Osaka

#2,797 in Japan

#28,822 in the World

Ono Pharmaceuticals Co., Ltd.

Forward Citations = 130

64 inventors:

Shinji Nakade (3 out of 17 patents)

Hiromu Habashita (3 out of 17 patents)

Fumio Nambu (3 out of 10 patents)

4. Shuichi Ohuchida (3 out of 43 patents)

5. Tohru Kambe (2 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ono Pharmaceuticals Co., Ltd.. Retrieved from https://idiyas.com/company/ono-pharmaceuticals-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…